LBX Pharmacy Chain Joint Stock Company (SHSE:603883) entered into an agreement to acquire remaining 49% stake in Taizhou Longtaiyuan Pharmaceutical Chain Co., Ltd. from Hainan Qitai Enterprise Management Partnership (Limited Partnership) for CNY 10.4 million on July 11, 2021. After the transaction is approved and implemented, LBX Pharmacy need to complete the payment of the equity transfer price as agreed by the two parties after the agreement takes effect, after the completion of the settlement and after the completion of the completion of the acquisition involving all tax and fee payment obligations. Upon completion, LBX Pharmacy will hold 100% stake in Taizhou Longtaiyuan Pharmaceutical. In related transactions, LBX Pharmacy Chain Joint Stock Company agreed to acquire remaining 35% stake in Zhenjiang Huakang Pharmacy Chain Co., Ltd. and 49% stake in Jiangsu Baijiahui Suheda Pharmacy Chain Co., Ltd. The transaction was funded by own funds of LBX Pharmacy. The transaction is subject to approval from shareholders of LBX Pharmacy and other possible approvals or approvals (if any) required by relevant laws and regulations. The transaction has been approved by the Board of LBX Pharmacy. As of August 20, 2021, shareholders of LBX Pharmacy Chain Joint Stock Company approved the transaction. Wei Qinghua of Dongxing Securities acted as financial advisor to LBX Pharmacy. Ding Shaobo, Xie Yongjun, Wu Juan, Wang Tianjiao and Zhao Chengjie of Hunan Qiyuan Law Firm acted as legal advisors, Li Dan, Chen Jianxiang and Shen Jing of PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) acted as accountants, Hu Shaoxian, Zhao Jiao and Zhou Ya of Pan-China Certified Public Accountants LLP and Fang Wensen, Chen Zhi and Wang Weihua of Zhongshenhua Certified Public Accountants (Special general partnership) acted as accountants to LBX Pharmacy. Hu Jiahao, He Yuanquan and Xie Songsha of Zhongrui Shilian Assets Appraisal Group Co., Ltd. acted as the appraisers for LBX Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company (SHSE:603883) completed the acquisition of remaining 49% stake in Taizhou Longtaiyuan Pharmaceutical Chain Co., Ltd. from Hainan Qitai Enterprise Management Partnership (Limited Partnership) on September 30, 2021.